MSTEP for Concussion
(MSTEP-R01 Trial)
Trial Summary
What is the purpose of this trial?
This trial tests a new exercise program called M-STEP that uses fitness trackers and video calls to help young people aged 11-18 recover from long-lasting concussion symptoms. The program aims to speed up recovery by gradually increasing physical activity and reducing fear of symptoms.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on using exercise to treat concussion symptoms.
What data supports the effectiveness of the treatment MSTEP for concussion?
Research suggests that subsymptom threshold exercise, which is part of the MSTEP program, can help reduce symptoms and improve recovery in people with persistent post-concussion symptoms. Studies have shown that structured aerobic exercise and physical interventions can lead to faster recovery and symptom improvement after a concussion.12345
Is the Mobile Subthreshold Exercise Program (MSTEP) safe for use in humans?
How is the MSTEP treatment for concussion different from other treatments?
MSTEP is unique because it delivers subthreshold exercise (exercise below the level that causes symptoms) virtually through telehealth, using tools like Zoom and fitness devices, making it accessible for youth in rural areas or during situations like the COVID-19 pandemic, unlike traditional treatments that require in-person visits.167910
Research Team
Sara P Chrisman, MD
Principal Investigator
University of Washington and Seattle Children's Hospital
Eligibility Criteria
This trial is for English or Spanish-speaking youth aged 11-18 with persistent post-concussive symptoms from a concussion diagnosed between 1 week to 12 months prior. Participants must have at least three concussive symptoms and minimal current physical activity. Those already cleared for sports or treated by a Physical Therapist for aerobic activity are excluded.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the M-STEP intervention or stretching control for 6 weeks, with weekly video conferencing and use of Fitbits for progress tracking
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at multiple time points
Treatment Details
Interventions
- MSTEP (Behavioural Intervention)
- Stretching (Behavioural Intervention)
MSTEP is already approved in Canada for the following indications:
- Persistent Post-Concussive Symptoms (PPCS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Seattle Children's Hospital
Lead Sponsor
Dr. Jeff Sperring
Seattle Children's Hospital
Chief Executive Officer since 2015
MD from Indiana University School of Medicine
Dr. Jeff Ojemann
Seattle Children's Hospital
Chief Medical Officer since 2022
MD from Washington University in St. Louis
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
Dr. Diana W. Bianchi
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Chief Executive Officer since 2016
MD from Stanford University
Dr. Alison Cernich
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Chief Medical Officer since 2020
PhD in Clinical Psychology from University of Maryland